TRCT
AMN icon

Tower Research Capital (TRC)’s AMN Healthcare AMN Stock Holding History

Tower Research Capital (TRC)’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.4K Sell
3,130
-1,700
-35% -$32.3K ﹤0.01% 2619
2025
Q4 		$76.1K Sell
4,830
-3,406
-41% -$60.8K ﹤0.01% 2136
2025
Q3 		$159K Buy
8,236
+5,143
+166% +$100K ﹤0.01% 1649
2025
Q2 		$63.9K Buy
3,093
+1,020
+49% +$21.2K ﹤0.01% 2759
2025
Q1 		$50.7K Sell
2,073
-75
-3% -$1.93K ﹤0.01% 2225
2024
Q4 		$51.4K Sell
2,148
-1,784
-45% -$56.7K ﹤0.01% 2537
2024
Q3 		$167K Sell
3,932
-6,144
-61% -$322K ﹤0.01% 1783
2024
Q2 		$516K Buy
10,076
+9,087
+919% +$515K 0.01% 1308
2024
Q1 		$61.8K Sell
989
-11,709
-92% -$797K ﹤0.01% 2133
2023
Q4 		$951K Buy
12,698
+11,779
+1,282% +$843K 0.01% 888
2023
Q3 		$78.3K Sell
919
-523
-36% -$49.6K ﹤0.01% 2166
2023
Q2 		$157K Buy
1,442
+222
+18% +$21K 0.01% 1728
2023
Q1 		$101K Sell
1,220
-3,779
-76% -$356K ﹤0.01% 1855
2022
Q4 		$514K Buy
4,999
+1,338
+37% +$154K 0.02% 686
2022
Q3 		$388K Buy
3,661
+2,128
+139% +$233K 0.01% 1337
2022
Q2 		$169K Buy
1,533
+1,136
+286% +$112K ﹤0.01% 1898
2022
Q1 		$41K Buy
397
+28
+8% +$2.91K ﹤0.01% 2881
2021
Q4 		$45K Sell
369
-2,283
-86% -$253K ﹤0.01% 2836
2021
Q3 		$304K Buy
2,652
+1,830
+223% +$194K 0.01% 1388
2021
Q2 		$80K Sell
822
-4,151
-83% -$360K ﹤0.01% 2598
2021
Q1 		$367K Buy
4,973
+1,484
+43% +$110K 0.01% 1490
2020
Q4 		$238K Sell
3,489
-31,954
-90% -$2.08M 0.01% 1583
2020
Q3 		$2.07M Buy
35,443
+30,450
+610% +$1.6M 0.02% 367
2020
Q2 		$226K Buy
+4,993
New +$239K 0.01% 1688
2019
Q2 		– Sell
-2,400
Closed -$113K – 3624
2019
Q1 		$113K Buy
+2,400
New +$133K 0.01% 1384
2018
Q3 		– Sell
-3,260
Closed -$191K – 3723
2018
Q2 		$191K Buy
3,260
+1,705
+110% +$102K 0.01% 1088
2018
Q1 		$88K Buy
1,555
+1,279
+463% +$69.5K 0.01% 1343
2017
Q4 		$14K Sell
276
-1,519
-85% -$69.2K ﹤0.01% 2307
2017
Q3 		$82K Buy
1,795
+525
+41% +$20.1K 0.01% 1555
2017
Q2 		$50K Buy
1,270
+706
+125% +$27.1K 0.01% 745
2017
Q1 		$23K Buy
+564
New +$22.1K ﹤0.01% 1201
2016
Q3 		– Sell
-4,744
Closed -$190K – 3577
2016
Q2 		$190K Buy
+4,744
New +$175K 0.02% 693
2015
Q2 		– Sell
-3,739
Closed -$86K – 4332
2015
Q1 		$86K Buy
3,739
+3,427
+1,098% +$70.9K 0.01% 1013
2014
Q4 		$6K Sell
312
-3,863
-93% -$66.3K ﹤0.01% 2556
2014
Q3 		$66K Buy
4,175
+2,366
+131% +$33.7K 0.01% 1304
2014
Q2 		$22K Buy
1,809
+1,110
+159% +$13.3K ﹤0.01% 1779
2014
Q1 		$10K Sell
699
-1,947
-74% -$28K ﹤0.01% 2580
2013
Q4 		$39K Sell
2,646
-3,213
-55% -$43.5K 0.01% 1604
2013
Q3 		$80K Buy
+5,859
New +$86.1K 0.01% 1497

Other funds holding AMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Tower Research Capital (TRC)'s AMN Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its AMN Healthcare (AMN) stake by 35% in Q1 2026, selling an estimated $32.3K and leaving 3,130 shares worth $57.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Tower Research Capital (TRC) first reported a position in AMN in Q3 2013 and has held it in 39 quarters since. The position peaked at $2.07M in Q3 2020. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Tower Research Capital (TRC) held 3,130 shares of AMN Healthcare worth $57.4K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,700 AMN Healthcare shares in Q1 2026, an estimated $32.3K.
  • AMN Healthcare made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2619 holding.
  • Tower Research Capital (TRC) first reported a position in AMN Healthcare in Q3 2013 and has held it in 39 quarters since.
  • Tower Research Capital (TRC)'s AMN Healthcare position peaked at $2.07M in Q3 2020.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.